Clinical Trial

Amplification and Tinnitus Masker Performance and Benefit for Adults With Hearing Loss and Tinnitus

Study acronym: StarkeyPMCF
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This study is a Post-Market Clinical Investigation whose primary purpose is to evaluate hearing aid amplification and tinnitus masker performance for individuals with hearing loss and tinnitus. There are two primary hypotheses that will be assessed in this study: The use of well-fit amplification alone improves participants' ability to hear and improves tinnitus symptoms as compared to unaided conditions. The use of well-fit amplification in conjunction with a tinnitus masker improves participants' ability to hear and improves tinnitus symptoms as compared to unaided conditions. Participants will be fit with hearing aids for 6 months and a tinnitus masker will be activated at the 3-month mark of the study. Outcome measures will evaluate device performance and participant benefit from the devices throughout the study duration.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-19.
Status change: Recruiting → Enrolling by Invitation 2025-12-29
Trial Details
NCT Number NCT07298499
Lead Sponsor Starkey Laboratories, Inc
Conditions Hearing Aid, Tinnitus
Enrollment 100 participants
Start Date 2025-07-07
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-12-31